The article presents the experience and clinical and immunological effectiveness
of the use of recombinant human interleukin-2. The accumulated clinical
experience of the use of recombinant interleukin-2 in patients of different age
groups indicates the validity and expediency of including the drug in the basic
therapy of severe bacterial and viral infections, oncological diseases,
simultaneously with antimicrobial chemotherapy in order to normalize
immunological parameters and improve the clinical course of the disease, as well
as for timely and complete resolution of the inflammatory process.
The article presents the experience and clinical and immunological
substantiation of using immunoprophylaxis in the preparatory period for swimmers
of the "Masters" group. The accumulated clinical experience of using recombinant
interleukin-2 in athletes of various age groups and levels of training indicates
the validity and expediency of including recombinant interleukin-2 in training
programs in order to normalize immunological parameters and improve the adaptive
potential.
